A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma.

Autor: Younes, A.1 ayounes@mdanderson.org, Vose, J. M.2, Zelenetz, A. D.3, Smith, M. R.4, Burris, H. A.5, Ansell, S. M.6, Klein, J.7, Halpern, W.8, Miceli, R.7, Kumm, E.7, Fox, N. L.7, Czuczman, M. S.9
Zdroj: British Journal of Cancer. 12/7/2010, Vol. 103 Issue 12, p1783-1787. 5p. 2 Charts, 2 Graphs.
Databáze: Academic Search Ultimate